[go: up one dir, main page]

RU94016389A - CARBAMATS AND CARBAMIDES INDUCING CYTOKINE PRODUCTION - Google Patents

CARBAMATS AND CARBAMIDES INDUCING CYTOKINE PRODUCTION

Info

Publication number
RU94016389A
RU94016389A RU94016389/04A RU94016389A RU94016389A RU 94016389 A RU94016389 A RU 94016389A RU 94016389/04 A RU94016389/04 A RU 94016389/04A RU 94016389 A RU94016389 A RU 94016389A RU 94016389 A RU94016389 A RU 94016389A
Authority
RU
Russia
Prior art keywords
carbamides
cytokine production
carbamats
inducing cytokine
compounds
Prior art date
Application number
RU94016389/04A
Other languages
Russian (ru)
Other versions
RU2135515C1 (en
Inventor
Айрал-Калоустиан Семирамиз
Р.Шоу Стивен
Т.Ду Мила
Дж.Гиббонс Джеймс (младший)
Original Assignee
Американ Цианамид Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/063,174 external-priority patent/US5312831A/en
Application filed by Американ Цианамид Компани filed Critical Американ Цианамид Компани
Publication of RU94016389A publication Critical patent/RU94016389A/en
Application granted granted Critical
Publication of RU2135515C1 publication Critical patent/RU2135515C1/en

Links

Claims (1)

Изобретение относится к новым карбамидам и карбаматам:
Figure 00000001

которые стимулируют продуцирование цитокинов и могут быть использованы для ускорения выздоровления при нейтропении, сопровождающей радио- и химиотерапию, трансплантацию костного мозга или инфекционные заболевания. Соединения изобретения или фармацевтические композиции, применяющие эти соединения, могут быть полезны при лечении злокачественных опухолей, СПИДа, апластической анемии, миелодиспластического синдрома, инфекционных заболеваний и для усиления имунной реакции.The invention relates to new carbamides and carbamates:
Figure 00000001

which stimulate cytokine production and can be used to accelerate recovery from neutropenia accompanying radio and chemotherapy, bone marrow transplantation or infectious diseases. The compounds of the invention or pharmaceutical compositions employing these compounds may be useful in the treatment of malignant tumors, AIDS, aplastic anemia, myelodysplastic syndrome, infectious diseases and to enhance the immune response.
RU94016389A 1993-05-12 1994-05-11 Cytokines production-inducing carbamates and ureas RU2135515C1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/063.174 1993-05-12
US08/063,174 US5312831A (en) 1993-05-12 1993-05-12 Urethanes and ureas that induce cytokine production

Publications (2)

Publication Number Publication Date
RU94016389A true RU94016389A (en) 1996-01-10
RU2135515C1 RU2135515C1 (en) 1999-08-27

Family

ID=22047440

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94016389A RU2135515C1 (en) 1993-05-12 1994-05-11 Cytokines production-inducing carbamates and ureas

Country Status (26)

Country Link
US (6) US5312831A (en)
EP (1) EP0652228B1 (en)
JP (1) JP3583469B2 (en)
KR (1) KR100296543B1 (en)
CN (1) CN1094943C (en)
AT (1) ATE144533T1 (en)
AU (1) AU669064B2 (en)
CA (1) CA2123261A1 (en)
CZ (1) CZ290445B6 (en)
DE (1) DE69400798T2 (en)
DK (1) DK0652228T3 (en)
ES (1) ES2094004T3 (en)
FI (1) FI942186A7 (en)
GR (1) GR3022253T3 (en)
HU (1) HU219768B (en)
IL (1) IL109602A (en)
NO (1) NO311223B1 (en)
NZ (1) NZ260507A (en)
PH (1) PH30182A (en)
PL (1) PL179984B1 (en)
RU (1) RU2135515C1 (en)
SG (1) SG43071A1 (en)
SI (1) SI0652228T1 (en)
SK (1) SK281120B6 (en)
TW (1) TW380129B (en)
ZA (1) ZA943266B (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1007183A3 (en) * 1993-06-18 1995-04-18 Solvay Ureines DERIVED ALPHA, OMEGA-diamino AND METHOD FOR THEIR PREPARATION.
EP0809492A4 (en) * 1995-02-17 2007-01-24 Smithkline Beecham Corp Il-8 receptor antagonists
US6005008A (en) * 1996-02-16 1999-12-21 Smithkline Beecham Corporation IL-8 receptor antagonists
US6211373B1 (en) 1996-03-20 2001-04-03 Smithkline Beecham Corporation Phenyl urea antagonists of the IL-8 receptor
US6262113B1 (en) 1996-03-20 2001-07-17 Smithkline Beecham Corporation IL-8 receptor antagonists
IL127666A0 (en) * 1996-06-27 1999-10-28 Smithkline Beecham Corp IL-8 receptor antagonists
BR9709938A (en) 1996-06-27 1999-08-10 Smithkline Beecham Corp Il-8 receptor antagonists
WO1998006398A1 (en) * 1996-08-15 1998-02-19 Smithkline Beecham Corporation Il-8 receptor antagonists
US6492370B1 (en) 1998-03-26 2002-12-10 Santen Pharmaceutical Co., Ltd. Urea derivatives and pharmaceutical compositions thereof
US7465754B1 (en) 1999-09-15 2008-12-16 Wyeth Method of potentiating chemotherapy and treating solid tumors
KR101208266B1 (en) * 2002-03-22 2012-12-05 에자이 알앤드디 매니지먼트 가부시키가이샤 Hemiasterlin derivatives and uses thereof
US7332158B2 (en) * 2002-05-29 2008-02-19 Demao Yang Compositions and treatments for myelosuppression by ex vivo activated immune cells
US7048922B2 (en) * 2002-05-29 2006-05-23 Demao Yang Stimulation of hematopoiesis by ex vivo activated immune cells
MY143477A (en) * 2002-10-29 2011-05-31 Smithkline Beecham Corp Il-8 receptor antagonists
US20060057121A1 (en) * 2004-09-10 2006-03-16 Demao Yang Compositions and treatments using ex vivo activated cells for myelosuppressed patients
UA98456C2 (en) * 2006-04-21 2012-05-25 Смитклайн Бичам Корпорейшн Il-8 receptor antagonists
WO2007124423A2 (en) * 2006-04-21 2007-11-01 Smithkline Beecham Corporation Il-8 receptor antagonists
CL2007001829A1 (en) * 2006-06-23 2008-01-25 Smithkline Beecham Corp N- [4-Chloro-2-hydroxy-3- (piperazine-1-sulfonyl) phenyl] -n- (2-chloro-3-fluorophenyl) urea P-toluenesulfonate; preparation process; pharmaceutical composition; pharmaceutical combination; and use in the treatment of a disease mediated by chemokine il-8, such as asthma and epoc.
US10913922B2 (en) 2012-03-30 2021-02-09 Givaudan S.A. N-acylated methionine derivatives as food flavoring compounds
KR102045591B1 (en) 2012-03-30 2019-12-02 지보당 에스아 N-acyl derivatives of gamma amino-butyric acid and beta alanine as food flavouring compounds
SG11201405104PA (en) 2012-03-30 2014-10-30 Givaudan Sa Improvements in or relating to organic compounds
WO2013149025A1 (en) * 2012-03-30 2013-10-03 Givaudan, S., A. N-acyl serine derivatives as food flavouring compounds
US10582715B2 (en) 2012-03-30 2020-03-10 Givaudan Sa Powder flavour composition
JP6224072B2 (en) 2012-03-30 2017-11-01 ジボダン エス エー N-acyl-amino acid derivatives for improving flavor profile edible compositions
KR102045592B1 (en) 2012-03-30 2019-11-15 지보당 에스아 N-acyl proline derivatives as food flavouring compounds
KR102045590B1 (en) 2012-03-30 2019-11-15 지보당 에스아 N-acylated 1-aminocycloalkyl carboxylic acids as food flavouring compounds
GB201317424D0 (en) * 2013-10-02 2013-11-13 Givaudan Sa Improvements in or relating to organic compounds
CN105592720B (en) 2013-10-02 2020-07-07 奇华顿股份有限公司 Organic compounds with taste-improving properties
CN105636459A (en) 2013-10-02 2016-06-01 奇华顿股份有限公司 Organic compounds
CN105592719B (en) 2013-10-02 2020-03-10 奇华顿股份有限公司 organic compounds
EP3052472B1 (en) 2013-10-02 2019-02-27 Givaudan S.A. N-acylated 2-aminoisobutyric acid compounds and flavour compositions containing them
WO2015050535A1 (en) 2013-10-02 2015-04-09 Givaudan S.A. Organic compounds
US10834943B2 (en) 2013-10-02 2020-11-17 Givaudan S.A. Organic compounds having taste-modifying properties
US10537127B2 (en) 2013-10-02 2020-01-21 Givaudan S.A. Organic compounds
JP7399846B2 (en) 2017-08-21 2023-12-18 セルジーン コーポレイション Preparation process of (S)-TERT-butyl 4,5-diamino-5-oxopentanoate
CN109601739B (en) * 2019-01-17 2022-10-14 河南湾流生物科技有限公司 A kind of compound amino acid feed additive and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2033906B (en) * 1978-10-19 1982-12-01 Anvar Water-soluble compounds derived from extracts of streptomyces stimulosus process for their production and compositions containing them
US4725582A (en) * 1978-11-14 1988-02-16 Fujisawa Pharmaceutical Company, Ltd. Peptide, process for preparation thereof and use thereof
US4349466A (en) * 1978-11-14 1982-09-14 Fujisawa Pharmaceutical Co Peptide, process for preparation thereof and use thereof
FR2460290A1 (en) * 1979-06-29 1981-01-23 Rhone Poulenc Ind NOVEL TETRA- OR PENTAPEPTIDES, THEIR PREPARATION AND THE MEDICINES THAT CONTAIN THEM
ES8604609A1 (en) * 1985-07-02 1986-02-01 Uriach & Cia Sa J Process for the preparation of 1-[N-[1(R,S)-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl]-L-proline
AU664210B2 (en) * 1991-09-27 1995-11-09 Board Of Regents, The University Of Texas System Amino acids containing parenteral formulations for the treatment of hypotension and related pathologies

Similar Documents

Publication Publication Date Title
RU94016389A (en) CARBAMATS AND CARBAMIDES INDUCING CYTOKINE PRODUCTION
SG43071A1 (en) Urethanes and ureas that induce cytokine production
RU93048636A (en) 7- / SUBSTITUTED / -8- / SUBSTITUTED / -9- / SUBSTITUTED AMINO / -6-DIMETHYL-6-DEOXYTETRACYCLINES, INTERMEDIATE COMPOUNDS, METHODS FOR PRODUCING COMPOUNDS, METHOD FOR PREVENTION AND TREATMENT
DK0604418T3 (en) Isolated viral protein cytokine antagonists
RU93033479A (en) METHOD FOR OBTAINING SUBSTITUTED PYRROLES, METHOD FOR OBTAINING PHARMACEUTICAL PREPARATIONS
LU92060I2 (en) Interferon beta-1a
ES2063278T3 (en) MORPHOGENETIC PROTEIN OF BONE.
EP2316486A3 (en) Cripto blocking antibodies and uses thereof
RU93004574A (en) CYCLOSPORINS, METHOD OF THEIR PRODUCTION AND A PHARMOCOMPOSITION ON THEIR BASIS
IL160511A0 (en) Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease
NL190399C (en) Iron-containing protein material, preparation thereof, and pharmaceutical composition for the treatment of sideropenic anemia.
EP2014291A3 (en) Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment
ES2128348T3 (en) OBTAINING COMPOSITIONS FOR THE TREATMENT OF ALTERATIONS OF CELL PROLIFERATION.
ATE341339T1 (en) COMPOSITIONS OF RECOMBINANT PAPILLOMAVIRUS VACCINES
ATE285253T1 (en) BETA INTERFERON FOR THE TREATMENT OF IMMUNE DISEASES
ES2142840T3 (en) PROTEIN THAT JOINS THE ALPHA / BETA INTERFERON, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
AU2003225661A8 (en) Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
EP1878794A3 (en) Compositions and methods for the treatment of immune related diseases
WO2002090383A3 (en) M. catarrhalis antigens
HK1077757A (en) Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease
IT9021564A0 (en) PROCESS FOR THE PURIFICATION OF RECOMBINANT HUMAN BETA-INTERFERON, PURIFIED BETA-INTERFERON AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT
RU93034452A (en) HINAZOLIN DERIVATIVES FOR ENHANCING ANTI-TUMOR ACTIVITY, METHOD FOR THEIR PRODUCTION, METHOD OF TREATMENT AND PHARMACEUTICAL COMPOSITION
RU92016532A (en) BENZOCHINAZOLINE COMPOUNDS, METHOD FOR PRODUCING THEM, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT
IT1237806B (en) PROCESS FOR THE PREPARATION OF FINE NITRIDE ALUMINUM POWDERS FROM AL303 AND COAL
IT8919196A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ISCHEMIC STROKE.